Related Experiment Video

Updated: Jul 11, 2026

A Model of Chronic Nutrient Infusion in the Rat
08:18

A Model of Chronic Nutrient Infusion in the Rat

Published on: August 14, 2013

A radical explanation for glucose-induced beta cell dysfunction

Michael Brownlee1

  • 1Diabetes Research Center, Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, New York 10461, USA. Brownlee@aecom.yu.edu

The Journal of Clinical Investigation
|December 18, 2003
PubMed

Insights

High blood sugar impairs insulin secretion by activating mitochondrial superoxide production in beta cells. Inhibiting this process may prevent type 2 diabetes progression.

Area of Science:

  • Endocrinology
  • Metabolic diseases
  • Cellular biology

Background:

  • Type 2 diabetes is characterized by impaired beta cell function.
  • Hyperglycemia exacerbates beta cell dysfunction by reducing insulin secretion.

Purpose of the Study:

  • To investigate the mechanism by which hyperglycemia impairs beta cell function.
  • To explore the role of mitochondrial superoxide production and uncoupling protein 2.

Main Methods:

  • The study examined the effects of hyperglycemia on mitochondrial superoxide production in beta cells.
  • Researchers assessed the activation of uncoupling protein 2 and its impact on the ATP/ADP ratio.
  • Insulin secretion response under hyperglycemic conditions was measured.

Main Results:

  • Hyperglycemia induces mitochondrial superoxide production in beta cells.
  • This superoxide production activates uncoupling protein 2.
  • Uncoupling protein 2 activation lowers the ATP/ADP ratio, reducing insulin secretion.

Conclusions:

  • Hyperglycemia-induced mitochondrial superoxide production creates a feed-forward loop of glucotoxicity.
  • Inhibiting mitochondrial superoxide overproduction could be a therapeutic strategy for type 2 diabetes.
  • Preventing this loop may halt the progression from impaired glucose tolerance to type 2 diabetes.

More Related Videos

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

Analysis of Beta-cell Function Using Single-cell Resolution Calcium Imaging in Zebrafish Islets08:50

Analysis of Beta-cell Function Using Single-cell Resolution Calcium Imaging in Zebrafish Islets

Published on: July 3, 2018

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...